Patient P-02642
Therapy response
Declining
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
37%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S14
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+6
- Treatment adherence-6
- Inflammatory activity+4
- Toxicity+4
- Nutritional resilience-2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients.
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↑35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 35 ms, trending down
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
- GLP1R rs6923761 AAltered receptor sensitivity
Microbiome
Shannon diversity 4.5 · butyrate capacity 46/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 36 ms
- Sleep
- 6.0 h
- Steps
- 6,064
- Resting HR
- 68 bpm
Daily log: GI score 26, nutritional resilience 60, adherence 87.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02276 | 48% | S01 | — | — | 57 |
| P-02568 | 42% | S01 | — | — | 51 |
| P-02307 | 41% | S01 | — | — | 55 |
| P-02598 | 41% | S01 | — | — | 53 |
| P-02550 | 39% | S01 | — | — | 70 |
| P-02620 | 39% | S01 | HY-01 | improved | 64 |
| P-02218 | 38% | S01 | DT-01 | improved | 61 |
| P-02681 | 38% | S01 | — | — | 51 |
| P-02217 | 37% | S01 | — | — | 61 |
| P-02354 | 37% | S01 | CR-01 | improved | 78 |
| P-02437 | 37% | S01 | — | — | 64 |
| P-02087 | 36% | S01 | BR-03 | no change | 40 |